Benzinga | Oct 29, 2020 05:59AM EDT

JP Morgan Downgrades ChemoCentryx to Neutral, Lowers Price Target to $60

JP Morgan analyst Anupam Rama downgrades ChemoCentryx (NASDAQ:CCXI) from Overweight to Neutral and lowers the price target from $63 to $60.